Inactive Instrument

Principia Biopharma Inc.

PRNB

US74257L1089

Biotechnology & Medical Research

Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell Small Cap Completeness Index

September 28, 2020 at 09:30 am IST

Latest news about Principia Biopharma Inc.

Goodwin : Sanofi buys Kymab for up to $1.5 billion to expand in immunotherapy	11/21/11	RE
Principia Biopharma Inc. Completes Patient Enrollment into the Global Phase 3 PEGASUS Trial for Rilzabrutinib	24/20/24	CI
Kiadis Pharma N : Healthcare group Sanofi offers to buy smaller peer Kiadis for 308 mln euros	02/20/02	RE
GLOBAL MARKETS LIVE: Google wins Fitbit, Epic Games loses first court battle against Apple…	29/20/29
Principia Biopharma Inc. Provides Information to Shareholders.	28/20/28	CI
Principia Biopharma Inc. Announces Executive Resignations	28/20/28	CI
Principia Biopharma Inc.(NasdaqGS:PRNB) dropped from S&P TMI Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGS:PRNB) dropped from S&P Biotechnology Select Industry Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGS:PRNB) dropped from S&P Global BMI Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2000 Value-Dynamic Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2500 Growth-Dynamic Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2500 Value-Dynamic Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 3000 Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2000 Growth Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2000 Value Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell Small Cap Completeness Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2500 Value Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2500 Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2000 Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 3000 Value Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell Small Cap Comp Growth Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell Small Cap Comp Value Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2500 Growth Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 3000 Growth Index	28/20/28	CI
Principia Biopharma Inc.(NasdaqGM:PRNB) dropped from Russell 2000 Growth-Dynamic Index	28/20/28	CI

Chart Principia Biopharma Inc.

Duration

Period

More charts

Principia Biopharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies to patients with unmet medical needs in immunology and oncology. It uses its Tailored Covalency platform to design and develop reversible covalent and irreversible covalent, small molecule inhibitors. Its pipeline includes PRN1008, PRN1371 and PRN2246. PRN1008 drug candidate is designed for the treatment of chronic immunological disorders. PRN2246 is an irreversible covalent BTK inhibitor for the treatment of multiple sclerosis (MS), and other central nervous system (CNS) diseases. PRN1008 is also being developed for the treatment of multiple autoimmune diseases, such as pemphigus. PRN1371 is an inhibitor of Fibroblast Growth Factor Receptor (FGFR), designed for the treatment of solid tumors. The Company also focuses on developing oral immunoproteasome inhibitor for the treatment of inflammation and autoimmune disorders.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+4.02%	111B
REGENERON PHARMACEUTICALS, INC.	+11.47%	105B
BIONTECH SE	-12.66%	22.34B
ARGENX SE	-3.70%	21.93B
GENMAB A/S	-6.03%	18.59B
WUXI APPTEC CO., LTD.	-35.21%	18.12B
BEIGENE, LTD.	-10.07%	16.96B
NEUROCRINE BIOSCIENCES, INC.	+2.55%	13.7B
SAREPTA THERAPEUTICS, INC.	+35.94%	12.45B

Bio Therapeutic Drugs